- Product Partners
- Supplements Facts
- Scientific References
- Client Reviews
Made With USP Verified Pure and Potent Fish Oil
Fish oil supplements can be a very helpful way to boost your intake of two crucial omega-3 fatty acids, EPA and DHA.
But not any fish oil supplement will do. There are three common problems with fish oil supplements: 1) No verification for purity to ensure harmful toxin and contaminant levels aren’t present, 2) Precautions aren’t taken to ensure the oil doesn’t get oxidized and lose nutritional value and 3) Insufficient EPA and DHA amounts.
Lots of companies claim their fish oil is free of harmful contaminants, but the fact is that the specific MEG-3® fish oil found in TrueOmega-3™ is verified both pure and potent by the independent USP board.
The oil is made from very small fish species such as anchovies, sardines and mackerel. Using small fish is a great starting point because they don’t have nearly the toxin buildup of larger more fatty fish like salmon or tuna.
As important is the sea where the fish live. With TrueOmega-3™, you get oil from fish harvested from one of the few remaining pristine ocean environments in the world - the waters off the coast of Peru.
But even in such pristine waters, fish can still contain contaminants. So once the fish are caught and the oil is extracted, a special “molecular distillation” purification method is used to remove metals or contaminants and deodorize the fish oil.
As part of the purification process, compounds that make the fish oil more prone to oxidation called “aldehydes” are removed, which helps to ensure freshness. Mixed tocopherols are also added to prevent oxidation damage which can turn the oil rancid and destroys potency.
Finally, each serving of TrueOmega-3™ provides a total of 818mg of EPA and DHA. When combined with the 50mg to 100mg typically provided from the American diet daily, this amounts to consumption levels frequently recommended for maintaining good health and wellness.
TrueOmega-3™ - Made with the First and Only Fish Oil Verified
Dietary Supplement / 60 Soft Gels
Serving Size: 2 softgels
Servings per Container: 30
|Amount Per Serving||% Daily Value|
|Calories from Fat||12|
|Fish Oil||1300 mg||**|
|Omega-3 Fatty Acids:|
|EPA (eicosapentaenoic acid)||468mg||**|
|DHA (docosahexaenoic acid)||350mg||**|
|Mixed Tocopherols||3 mg||**|
* Percent Daily Values Are Based on a 2000 Calorie Diet
** Daily Value not established.
Other Ingredients: Gelatin, glycerin and purified water, turmeric, soybean oil and sunflower oil.
Contains fish - anchovy, sardine, mackerel, skipjack, yellowfin, albacore, bigeye.
MEG-3® is a trademark of DSM.
Suggested Use: Take two (2) soft gels once or twice daily with meals.
TrueOmega-3™ promotes cardiovascular, brain and joint health with†:
The first fish oil to be USP verified for purity and potency.
A total of 818mg per serving (2 soft gels) of EPA and DHA, the omega-3 fatty acids recommended for consumption by medical scientists and authorities.
Natural vitamin E in the form of mixed tocopherols and a turmeric coating to protect the fish oil from oxidation damage.
All in easy to swallow soft gels!
Keep out of reach of children.
Store at 15-30° C (59-86° F).
Protect from heat, light and moisture.
Do not purchase if seal is broken.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Szu-Yun Wu, Jordi Mayneris-Perxachs, Julie A Lovegrove, Susan Todd, and Parveen Yaqoob. “Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype.” American Journal of Clinical Nutrition. November, 2014 100: 1232-1243.
Kuan-Pin Su, Hsueh-Chou Lai, Hui-Ting Yang, Wen-Pang Su, Cheng-Yuan Peng, Jane Pei-Chen Chang, Hui-Chih Chang, Carmine M. Pariante. “Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial.” Biological Psychiatry. October 1, 2014, Volume 76, Issue 7, Pages 559–566.
A.Z. Naqvi, H. Hasturk, L. Mu, R.S. Phillips, R.B. Davis, S. Halem, H. Campos, J.M. Goodson, T.E. Van Dyke, and K.J. Mukamal. “Docosahexaenoic Acid and Periodontitis in Adults: A Randomized Controlled Trial.” Journal of Dental Research. August 2014; vol. 93, 8: pp. 767-773.
Daiello LA, Gongvatana A, Dunsiger S, Cohen RA, Ott BR. “Association of fish oil supplement use with preservation of brain volume and cognitive function.” Alzheimer’s & Dementia. 2014 Jun 18. pii: S1552-5260(14)00079-X.
Wang X, Zhu M, Hjorth E, Cortés-Toro V, Eyjolfsdottir H, Graff C, Nennesmo I, Palmblad J. “Resolution of inflammation is altered in Alzheimer's disease.” Alzheimer’s & Dementia. February, 2014, Vol. 11, Issue 1, p40–50.e2.
Virtanen J, Siscovick D, Lemaitre R, Longstreth W, Spiegelman D, Rimm E, King I, Mozaffarian D. “Circulating Omega-3 Polyunsaturated Fatty Acids and Subclinical Brain Abnormalities on MRI in Older Adults: The Cardiovascular Health Study.” Journal of the American Heart Association. October, 2013;2:e000305.
Sheppard J, Singh R, McClellan A, Weikert M, Scoper S, Joly T, Whitley W, Kakkar E, Pflugfelder S. “Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial.” Cornea. October 2013, Volume 32, Issue 10, Pages 1297-1304.
Pirillo A, Catapano A. “Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia.” International Journal of Cardiology. July, 2013. Vol. 170, Issue 2, S16–S20.
Sauder KSkulas-Ray A, Campbell T, Johnson J, Kris-Etherton P, West S. “Effects of Omega-3 Fatty Acid Supplementation on Heart Rate Variability at Rest and During Acute Stress in Adults With Moderate Hypertriglyceridemia.” Psychosomatic Medicine. 2013 May; 75(4): 382–389.
Wong A, Chan D, Barrett P, Adams L, Watts G. “Supplementation with n3 Fatty Acid Ethyl Esters Increases Large and Small Artery Elasticity in Obese Adults on a Weight Loss Diet.” The Journal of Nutrition. April, 2013 143: 437-441.
Orchard T, Ing S, Lu B, Belury M, Johnson K, Wactawski-Wende J, Jackson R. “The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative.” Journal of Bone and Mineral Research. March 2013, Volume 28, Issue 3, pages 505–515.
Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R. “Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial.” Brain, Behavior, and Immunity. 2012 Aug;26(6):988-95.
Gabbay V, Babb J, Klein R, Panzer A, Katz Y, Alonso C, Petkova E, Wang J, Coffey B. “A Double-Blind, Placebo-Controlled Trial of Omega-3 Fatty Acids in Tourette’s Disorder.” Pediatrics. 2012 Jun; 129(6): e1493–e1500.
Lok C, Moist L, Hemmelgarn B, Tonelli M, Vazquez M, Dorval M, Oliver M, Donnelly S, Allon M, Stanley K. “Effect of Fish Oil Supplementation on Graft Patency and Cardiovascular Events Among Patients With New Synthetic Arteriovenous Hemodialysis Grafts.” The Journal of the American Medical Association. May, 2012;307 (17): 1809-1816.
Meldrum SJ, D'Vaz N, Dunstan J, Mori TA, Prescott SL. “Infant Fish Oil Supplementation Study: Design & research protocol of a double-blind, randomised controlled n--3 LCPUFA intervention trial in term infants.” Contemporary Clinical Trials. September, 2011 (32): 771- 778.
Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. “Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.” Cancer. 2011 Aug 15;117(16):3774-80.
Dangour A, Allen E, Elbourne D, Fasey N, Fletcher A, Hardy P, Holder G, Knight R, Letley L, Richards M, Uauy R. “Effect of 2-y n−3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.” American Journal of Clinical Nutrition. 2010. May.
Montegaard C, Tulk HM, Lauritzen L, Tholstrup T, Robinson LE. “Acute ingestion of long-chain (n-3) polyunsaturated fatty acids decreases fibrinolysis in men with metabolic syndrome.” Journal of Nutrition. 2010 Jan;140(1):38-43.
Metherel AH, Armstrong JM, Patterson AC, Stark KD. “Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women.” Prostaglandins, Leukotrienes and Essential Fatty Acids. 2009 Jul;81(1):23-9.
Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A. “Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis.” International Journal of Cardiology. 2009 Jul 24;136(1):4-16.
Hanwell HE, Kay CD, Lampe JW, Holub BJ, Duncan AM. “Acute fish oil and soy isoflavone supplementation increase postprandial serum (n-3) polyunsaturated fatty acids and isoflavones but do not affect triacylglycerols or biomarkers of oxidative stress in overweight and obese hypertriglyceridemic men.” Journal of Nutrition. 2009 Jun;139(6):1128-34.
Kitson A, Patterson A, Izadi H, Stark K. “Pan-frying salmon in an eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) enriched margarine prevents EPA and DHA loss.” Food Chemistry. Volume 114, Issue 3, 1 June 2009, Pages 927–932.
Barrow C, Nolan C, Holub B. “Bioequivalence of encapsulated and microencapsulated fish oil supplementation. “ Journal of Functional Foods. January, 2009. 1:38-43.
Martin L, Zarn D, Hansen AM, Wismer W, Mazurak V. “Food products as vehicles for n-3 fatty acid supplementation.” Canadian Journal of Dietetic Practice and Research. 2008 Winter;69(4):203-7.
Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, Armah CK, Kimber AC, Grew JP, Farrell L, Stannard J, Napper FL, Sala-Vila A, West AL, Mathers JC, Packard C, Williams CM, Calder PC, Minihane AM. “Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study.” American Journal of Clinical Nutrition. 2008 Sep;88(3):618-29.
Caron-Dorval D, Paquet P, Paradis AM, Rudkowska I, Lemieux S, Couture P, Vohl MC. “Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids.” Journal of Nutrigenetics and Nutrigenomics. June, 2008;1(4):205-12.
Armah CK, Jackson KG, Doman I, James L, Cheghani F, Minihane AM. “Fish oil fatty acids improve postprandial vascular reactivity in healthy men.” Clinical Science. 2008 Jun;114(11):679-86.
Vega GL, Chandalia M, Szczepaniak LS, Grundy SM. “Effects of N-3 fatty acids on hepatic triglyceride content in humans.” Journal of Investigative Medicine. 2008 Jun;56(5):780-5.
Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelstein G, Bodennec J. “Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids.” American Journal of Clinical Nutrition. 2008 May;87(5):1170-80.
Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN. “Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.” Nephrology Dialysis Transplantation. 2007 Dec;22(12):3561-7.
Goldberg RJ, Katz J. “A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.” Pain. 2007 May;129(1-2):210-23.
Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH. “Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.” American Journal of Psychiatry. 2006 Jun;163(6):1098-100.
Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. “Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects.” European Journal of Clinical Investigation. 2005 Nov;35(11):691-9.
Bouzan C, Cohen JT, Connor WE, Kris-Etherton PM, Gray GM, König A, Lawrence RS, Savitz DA, Teutsch SM. “A quantitative analysis of fish consumption and stroke risk.” American Journal of Preventive Medicine. 2005 Nov;29(4):347-52.
Bruce WR1, Cirocco M, Giacca A, Kim YI, Marcon N, Minkin S. “A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation.” British Journal of Cancer. 2005 Sep 19;93(6):639-46.
Young G, Conquer J, Thomas R. “Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder” Reproduction, Nutrition, Development. January, 2005, 45 (5), pp.549-558.
Buckley R, Shewring B, Turner R, Yaqoob P, Minihane A. “Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects.” British Journal of Nutrition. (2004, Sept), 92, 477–483.
Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM. “Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.” Circulation. 2004 Sep 21;110(12):1645-9.
Mesa MD, Buckley R, Minihane AM, Yaqoob P. “Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on the oxidizability and thrombogenicity of low-density lipoprotein.” Atherosclerosis. 2004 Aug;175(2):333-43.
Kew S, Mesa M, Tricon S, Buckley R, Minihane A, Yaqoob P. “Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans.” American Journal of Clinical Nutrition. April, 2004;79:674-81.
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. “Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial.” Journal of Allergy and Clinical Immunology. 2003 Dec;112(6):1178-84.
Stark K, Mulvad G, Pedersen H, Dewailly E. “Fatty acid compositions of serum phospholipids of postmenopausal women: a comparison between Greenland Inuit and Canadians before and after supplementation with fish oil.” Nutrition. July, 2002;18:627-30.
Stark K, Park E, Maines V, Holub B. “Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial.” American Journal of Clinical Nutrition. August, 2000;72:389-94.